Onco-Innovations Limited (NEO:ONCO)

Onco-Innovations Ratios and Metrics

Market cap in millions CAD. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Sep 9, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023
Market Capitalization	100	76	-	-
Enterprise Value	99	76	-	-
Last Close Price	1.85	1.50	-	-
PS Ratio	1537.95	1164.95	-	-
PB Ratio	55.62	42.13	-	-
P/TBV Ratio	55.62	42.13	-	-
EV/Sales Ratio	-	1158.58	-	-
Asset Turnover	0.05	0.05	-	-
Quick Ratio	2.94	2.94	3.47	-
Current Ratio	5.41	5.41	3.47	-
Return on Equity (ROE)	-799.79%	-799.79%	-233.40%	-
Return on Assets (ROA)	-144.12%	-144.12%	-105.54%	-
Return on Capital (ROIC)	-180.66%	-180.66%	-145.87%	-
Earnings Yield	-8.46%	-11.17%	-	-
Buyback Yield / Dilution	-	-905.82%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.